Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

otc:pwrm Press Releases

  + XML/RSS  



By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM) is a proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases.

By Karl McMahon
Helen R. Park, Hugh Hefner, NYSE:PLA, otc:pwrm, Playboy, power3 medical products, pwrm.ob

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies

By Karl McMahon
VisionChina Media Inc.(Nasdaq:VISN), one of China's largest out-of-home digital television advertising networks on mass transportation systems, and Focus Media Holding Limited

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM) is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the detection of breast cancer and neurological diseases.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM)a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases.

By Greg Lumpkin
Breast cancer rates now have fallen in recent times, even so medical professionals are not certain the key reason why.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases,

By Karl McMahon
Power3 has filed several patent applications for its NuroPro® technology that are currently pending.

By Greg Lumpkin
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases,

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM)delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Karl McMahon
Northrop Grumman Corporation (NYSE:NOC) announced the donation of a robust geospatial data set and capability to the Boy Scouts of America in support of their 100th anniversary and to help further scouting education.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Karl McMahon
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.

By Blayne Sheffield
PWRM.OB, HMA, RDN, & NVE: NV Energy, Inc. Reports Third Quarter Earnings

By Blayne Sheffield
Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas.

By Blayne Sheffield
NRO, ULU, SA, & PWRM.OB: Drills Upgrading Large Resource at Seabridge Gold's Courageous Lake Project

By Lynnette
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases

By Justin Handy
Stock Update On PWRM, TAXS, USB for August 31st, 2010 from PennyToBuck.com

By Justin Handy
Stock Highlight from PennyTOBuck on PROT, PWRM, ABT for Ausut 30th, 2010.

By Justin Handy
Stock Highlight On GENZ, PWRM, ENZ from PennytoBuck.com

By Justin Handy
PennyToBuck Stock Updates on PWRM, HLF, STEM for August 26th, 2010

By Justin Handy
PennyToBuck stock update on TAXS, JTX,PWRM,VRML and MRK.

By Hanson
Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.

By Justin Handy
KERX, a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases.

By Justin Handy
MRK reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor.

By Blayne Sheffield
PWRM.OB, ILMN, & VSYM.OB: ILMN has recently reported the production of the Eco Real-Time PCR System

By Blayne Sheffield
PWRM, MNTA, & SNY: Raul E. Kohan will be appointed Chief Executive Officer

By Justin Handy
LLY stated that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling that that Gemzar's method-of-use patent is invalid.

By Justin Handy
PWRM.ob has filed for patent protection for these findings and will be publishing these seminal results in the near future in one of the world’s most prestigious peer-reviewed scientific journals.

By Blayne Sheffield
MNTA, GENZ, & PWRM.OB: Biotech Stocks: Onyx, Genzyme, Momenta in spotlight

By DrStockPick
Power3 Medical Products, Inc. (OTCBB:PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies.

By DrStockPick
Power3 Medical Products is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

By Blayne Sheffield
GENZ, PWRM, & SNY: Blink on Friday And Miss Massive Biotech Spikes

By Blayne Sheffield
PWRM, ILMN, & CAH: Sequenom Rises as Ladenburg Says Buy, Jefferies Starts at Hold

By Blayne Sheffield
AFFX, LIFE, & OTC:PWRM: Affymetrix Launches Axiom Custom Genotyping Arrays Utilizing World's Largest Validated SNP Database

By Blayne Sheffield
SNY, GSK, & OTC:PWRM: Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes

By Lynn Lansky
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, recently announced that Glucose RapidSpray, is now available under a trial run at selected Boots UK retail chain stores.

By Blayne Sheffield
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery.

By Lynn Lansky
Power3 Medical Products (OTCBB: PWRM.OB) business focus is the development of commercial applications for their proprietary technologies.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share